Toward precision manufacturing of immunogene T-cell therapies.
Sign Up to like & getrecommendations! Published in 2018 at "Cytotherapy"
DOI: 10.1016/j.jcyt.2017.12.007
Abstract: Cancer can be effectively targeted using a patient's own T cells equipped with synthetic receptors, including chimeric antigen receptors (CARs) that redirect and reprogram these lymphocytes to mediate tumor rejection. Over the past two decades,… read more here.
Keywords: cell therapies; toward precision; precision manufacturing; immunogene cell ... See more keywords